BCSF remains a buy due to strong fundamentals, resilient earnings, low non-accruals, and a generous 11.4% dividend yield, despite recent price declines. BCSF's diverse portfolio, with 93.2% in floating rate debt, positions it well to benefit from the current high interest rate environment. Q1 earnings were solid, with net investment income of $0.50 per share, and the portfolio's NAV has remained stable, indicating effective strategy execution.

Bain Capital Specialty Finance, Inc. (NYSE:BCSF ) Q1 2025 Earnings Call May 6, 2025 8:30 AM ET Company Participants Katherine Schneider - Investor Relations Michael Ewald - Chief Executive Officer Mike Boyle - President Amit Joshi - Chief Financial Officer Conference Call Participants Paul Johnson - KBW Finian O'Shea - Wells Fargo Securities Derek Hewett - Bank of America Operator Good day, everyone and welcome to the Bain Capital Specialty Finance First Quarter ended March 31, 2025 Earnings Conference Call. [Operator Instructions] It is now my pleasure to turn the conference over to Katherine Schneider, Investor Relations.

BOSTON--(BUSINESS WIRE)--Bain Capital Specialty Finance, Inc. schedules earnings release for the first quarter ended March 31, 2025.

Bain Capital Specialty (BCSF) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

BOSTON--(BUSINESS WIRE)--Bain Capital Specialty Finance, Inc. schedules earnings release for the fourth quarter ended Dec. 31, 2024 on Thurs., Feb. 27, 2025 after market close.

Bain Capital Specialty Finance has shown strong performance with impressive earnings, solid portfolio quality, and effective management, making it a compelling buy for income-oriented investors. BCSF's portfolio growth and low non-accrual rates, combined with a healthy balance sheet and investment-grade credit ratings, highlight its financial stability and potential for continued growth. Despite trading at a slight discount to NAV, BCSF offers a near double-digit yield and strong dividend coverage, making it an attractive option for income-focused portfolios.

We take a look at the action in business development companies through the third week of January and highlight some of the key themes we are watching. BDCs had a strong week with a 3% total return, boosted this year by the unwinding of several Fed rate cuts. Blue Owl Capital Corp's merger with OBDE provided significant alpha opportunities due to OBDE's lower valuation.

We take a look at the action in business development companies through the second week of November and highlight some of the key themes we are watching. BDCs were flat this week in aggregate, outperforming other income sectors, with PSEC and TPVG bookending month-to-date returns. Q3 earnings reveal a slight decline in net investment income due to rate cuts, tight market spreads, and refinancing into higher coupon debt.

We take a look at the Q3 results of the BDC Bain Capital Specialty Finance. BCSF boasts strong performance and a cheap valuation, trading at a 10.6% dividend yield and 5% discount to book value. The company's ultra-low interest expense provides a competitive advantage for another 18 months, enhancing its yield spread above the sector median.

Bain Capital Specialty Finance (BCSF) remains a strong buy due to its low non-accrual rate, high dividend coverage, and strategic new investments, ensuring portfolio growth despite interest rate cuts. The portfolio is diverse with $2.4B spread across 159 companies, mitigating industry-specific risks. Financials are solid with net investment income at $0.53 per share, a growing NAV, and strategic investments primarily in senior secured first lien debt.